The company showcased new PET and SPECT technologies, imaging software, and radiopharmaceuticals aimed at supporting theranostics, quantitative imaging, and nuclear medicine workflows.
The U.S. FDA has approved Leqembi for Alzheimer’s treatment, which slows cognitive decline, but the Centers for Medicare & Medicaid Services have not committed to covering the necessary PET scans, according to Society of Nuclear Medicine and Molecular Imaging officials.
A collaboration by the Quantitative Imaging Biomarker Alliance (QIBA) of the Radiological Society of North America and EARL, an initiative of the European Association of Nuclear Medicine, is making inroads into international PET/CT harmonization.
According to new research, the imaging agent 64Cu-CuSarTate produced high-quality PET images in a mouse model of neuroendocrine tumors, while its therapeutic counterpart, 67Cu-CuSarTate, was highly effective in reducing tumor volume and extending lifespan.
Read More
A new method to treat hyperinsulinemic hypoglycemia has proven highly selective in targeting lesions and effective in slowing tumor growth, according to research published in the November issue of The Journal of Nuclear Medicine.
Read MoreSNMMI, along with the American Society of Nuclear Cardiology, the American Society for Radiation Oncology and the American College of Radiology, received a response from the U.S. Nuclear Regulatory Commission (NRC) regarding their request for regulatory relief for training for imaging and localization studies during the COVID-19 Public Health Emergency.
Read More
The Medical Imaging & Technology Alliance, along with the Council on Radionuclides and Radiopharmaceuticals, Inc. and SNMMI, hosted a virtual briefing for Capitol Hill staff on Wednesday, September 16, with leading physicians to discuss the extraordinary and growing impact of PET and nuclear medicine in cancer treatment.
Read More
A single-center observational study of more than 1,000 oncological examinations has demonstrated that PET/ MRI facilitates cancer staging as well as PET/CT and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.
Read More